Literature DB >> 16598201

Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS.

B A Young1, K Rudser, B Kestenbaum, S L Seliger, D Andress, E J Boyko.   

Abstract

African Americans have a greater risk of cardiovascular disease (CVD) than Caucasians in early chronic kidney disease; however, limited data describe racial and ethnic differences in the risk of incident myocardial infarction (MI) among patients with end-stage renal disease (ESRD). We conducted a prospective, observational cohort study among 271 102 incident dialysis patients receiving renal replacement therapy enrolled in the United States Renal Data System (USRDS) for whom Medicare was the primary insurer between 1995 and 2000. The incidence and risk of any MI (non-fatal or fatal) estimated by Cox proportional hazards models was the primary outcome of interest. Of those with prevalent CVD at baseline (118 708), 14 849 had an incident non-fatal MI compared with 9926 events for those without prevalent CVD (152 394). Patients with prevalent CVD had higher crude rates of combined fatal and non-fatal MI (99.3/1000 person-years vs 42.9/1000 person-years) compared with those without prevalent CVD. Among those with prevalent CVD, African Americans (adjusted relative risk (aRR)=0.65, 95% confidence interval (CI):0.62-0.68), Asian Americans (aRR=0.74, 95% CI: 0.66-0.83), and Hispanics (aRR=0.72, 95% CI: 0.68-0.77) were 26-35% less likely to have an incident MI compared to Caucasians. Similarly, among those without prevalent CVD, racial/ethnic minorities were 26-42% less likely to have an incident MI compared to Caucasians. We conclude that in a national setting where comparable access to dialysis and associated medical care, exist, racial/ethnic minorities were found to have a lower risk of non-fatal and fatal MI than Caucasians.

Entities:  

Mesh:

Year:  2006        PMID: 16598201     DOI: 10.1038/sj.ki.5000346

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  31 in total

1.  Inflammation and the paradox of racial differences in dialysis survival.

Authors:  Deidra C Crews; Stephen M Sozio; Yongmei Liu; Josef Coresh; Neil R Powe
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

2.  Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study.

Authors:  Jasmin Divers; Lynne E Wagenknecht; Donald W Bowden; J Jeffrey Carr; R Caresse Hightower; Thomas C Register; Jianzhao Xu; Carl D Langefeld; Barry I Freedman
Journal:  J Clin Endocrinol Metab       Date:  2010-09-01       Impact factor: 5.958

3.  Impact of activated vitamin D and race on survival among hemodialysis patients.

Authors:  Myles Wolf; Joseph Betancourt; Yuchiao Chang; Anand Shah; Ming Teng; Hector Tamez; Orlando Gutierrez; Carlos A Camargo; Michal Melamed; Keith Norris; Meir J Stampfer; Neil R Powe; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

Review 4.  Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Semin Dial       Date:  2010-05-10       Impact factor: 3.455

5.  Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.

Authors:  Thomas C Register; Keith A Hruska; Jasmin Divers; Donald W Bowden; Nicholette D Palmer; J Jeffrey Carr; Lynne E Wagenknecht; R Caresse Hightower; Jianzhao Xu; S Carrie Smith; Dennis J Dietzen; Carl D Langefeld; Barry I Freedman
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

6.  APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.

Authors:  Lijun Ma; Carl D Langefeld; Mary E Comeau; Jason A Bonomo; Michael V Rocco; John M Burkart; Jasmin Divers; Nicholette D Palmer; Pamela J Hicks; Donald W Bowden; Janice P Lea; Jenna O Krisher; Margo J Clay; Barry I Freedman
Journal:  Kidney Int       Date:  2016-05-06       Impact factor: 10.612

7.  Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.

Authors:  James P Lash; Ana C Ricardo; Jason Roy; Rajat Deo; Michael Fischer; John Flack; Jiang He; Martin Keane; Claudia Lora; Akinlolu Ojo; Mahboob Rahman; Susan Steigerwalt; Kaixiang Tao; Myles Wolf; Jackson T Wright; Alan S Go
Journal:  Am J Kidney Dis       Date:  2016-05-19       Impact factor: 8.860

8.  Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study.

Authors:  Barry I Freedman; Donald W Bowden; Julie T Ziegler; Carl D Langefeld; Allison B Lehtinen; Megan E Rudock; Leon Lenchik; Keith A Hruska; Thomas C Register; J Jeffrey Carr
Journal:  J Bone Miner Res       Date:  2009-10       Impact factor: 6.741

9.  Survival of patients from South Asian and Black populations starting renal replacement therapy in England and Wales.

Authors:  Paul Roderick; Catherine Byrne; Anna Casula; Retha Steenkamp; David Ansell; Richard Burden; Dorothea Nitsch; Terry Feest
Journal:  Nephrol Dial Transplant       Date:  2009-07-21       Impact factor: 5.992

10.  Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study.

Authors:  Jasmin Divers; Lynne E Wagenknecht; Donald W Bowden; J Jeffrey Carr; R Caresse Hightower; Jianzhao Xu; Carl D Langefeld; Barry I Freedman
Journal:  Diabetes Care       Date:  2009-10-13       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.